56 filings
S-8
ACRS
Aclaris Therapeutics Inc
8 May 23
Registration of securities for employees
4:05pm
424B5
ACRS
Aclaris Therapeutics Inc
23 Feb 23
Prospectus supplement for primary offering
4:03pm
S-8
ACRS
Aclaris Therapeutics Inc
10 May 22
Registration of securities for employees
8:01am
424B5
ACRS
Aclaris Therapeutics Inc
10 Jun 21
Prospectus supplement for primary offering
4:26pm
424B5
ACRS
Aclaris Therapeutics Inc
8 Jun 21
Prospectus supplement for primary offering
4:25pm
S-3ASR
b3dd1kjmth
20 May 21
Automatic shelf registration
4:56pm
S-8
9hqc2q7po rlmgo
7 May 21
Registration of securities for employees
4:45pm
424B5
jafpoe
20 Jan 21
Prospectus supplement for primary offering
5:00pm
S-3MEF
d388puzykfr4d j745jk
20 Jan 21
Registration of additional securities for an S-3
7:18am
424B5
cjui 9g4c
19 Jan 21
Prospectus supplement for primary offering
4:04pm
424B5
olnqnpnb6ltd llupk
13 Aug 20
Prospectus supplement for primary offering
5:26pm
S-8
pwd9u2qzf93 00ta8
7 May 20
Registration of securities for employees
5:02pm
424B5
hgaz866lefk3
29 Apr 20
Prospectus supplement for primary offering
4:03pm
D
zwkijnlxih0bzihgnx
7 Apr 20
$11.44M in debt / options / securities to be acquired, sold $11M, 1 investor
9:34pm
S-8
gd2oc bybse7dptcx
29 Mar 19
Registration of securities for employees
4:38pm
424B5
fgdroa rd8egf90tr
18 Oct 18
Prospectus supplement for primary offering
4:08pm
S-3MEF
m9pe h6wpgff0y
17 Oct 18
Registration of additional securities for an S-3
8:43pm
424B5
zade71y
17 Oct 18
Prospectus supplement for primary offering
4:04pm
D/A
ug0oyq0 pe
13 Aug 18
$12.5M in equity, sold $10M, 41 investors
2:24pm